Neural Tube Defects in the Neonatal Period

Updated: Dec 18, 2019
Author: Richard G Ellenbogen, MD; Chief Editor: Ted Rosenkrantz, MD 



Congenital deformities involving the coverings of the nervous system are called neural tube defects (NTDs). Neural tube defects vary in severity. The mildest form is spina bifida aperta, in which osseous fusion of one or more vertebral arches is lacking, without involvement of the underlying meninges or neural tissue. A slightly more severe form of spina bifida, which is discussed in detail in this article, is spina bifida cystica, or myelomeningocele, in which a saclike casing is filled with cerebrospinal fluid (CSF), spinal cord, and nerve roots that have herniated through a defect in the vertebral arches and dura, as shown below.

Neonate with a lumbar myelomeningocele with an L5 Neonate with a lumbar myelomeningocele with an L5 neurologic level. Note the diaphanous sac filled with cerebrospinal fluid and containing fragile vessels in its membrane. Also, note the neural placode plastered to the dorsal surface of the sac. This patient underwent closure of his back and an untethering of his neural placode. The neural placode was circumnavigated and placed in the neural canal. A dural sleeve was fashioned in such a way to reconstruct the neural tube geometry.

Anencephaly and rachischisis are extremely severe forms of neural tube defects, in which an extensive opening in the cranial and vertebral bone is present with an absence of variable amounts of the brain, spinal cord, nerve roots, and meninges. Anencephaly has been studied since antiquity, and an almost dizzying array of synonyms and classifications is noted.[1] For a more complete description of anencephaly, see the seminal work by Lemire, Beckwith, and Warkany in 1978.[2]

Malformations of the brain and spinal cord may result from genetic mutation or may be acquired deformities. Most malformations, especially those such as neural tube defects, occur early in embryogenesis and are likely the result of aberrant expression of a yet undefined developmental gene or family of genes. The nervous system develops in a precise temporal embryologic sequence; therefore, an interruption of one part of the developmental sequence often affects remaining development.

The neural tube defect discussed in this article is classified as an embryologic induction disorder. It results in failure to properly form both the mesoderm and neuroectoderm. The primary embryologic defect in all neural tube defects is failure of the neural tube to close, affecting neural and cutaneous ectodermal structures. The inciting event can be traced to days 17-30 of gestation.

The precise etiology and the specific genes that may be involved during this abnormal neural ontogenesis have not yet been elucidated. These deformities are not only disorders of embryologic induction but also disorders of cellular migration and include the secondary mechanical complications that occur with an unprotected nervous system. Specifically, the amniotic fluid can have a caustic and destructive effect on the open neural structures.[3]

As described, the primary defect is a failure of the neural folds to fuse in the midline and form the neural tube, which is neuroectoderm. However, the subsequent defect is the maldevelopment of the mesoderm, which, in turn, forms the skeletal and muscular structures that cover the underlying neural structures. These neural tube defects can be open (neural structures that communicate with the atmosphere) or closed (skin covered). They can be ventral or dorsal midline defects.


Neural tube defects (NTDs) are the second-most-common major congenital anomaly; only cardiac malformations are more common.[4] Several interesting characteristics in the epidemiology of NTDs are as follows:

  • In the United States, myelomeningoceles occur in about 1 of 1500 births.[5]

  • Significant ethnic differences in prevalence are recognized; people of Celtic origin have the highest rate of spina bifida.

  • A female predominance is observed, with females accounting for 60-70% of affected children.

  • Significant differences in geographic distribution are noted, with countries in the British Isles having a higher rate than Asian countries. However, in 2005, the Shanxi province in Northern China was reported to have one of the highest incidence rates of neural tube defects in the world. Many risks were associated with this increased rate, and factors that seemed to be protective included meat consumption, legume consumption, or both.

  • In a 2014 retrospective review (1996-2009) of 103 Saudi Arabian newborns admitted to the neonatal intensive care unit (NICU) with a diagnosis of neural tube defects, 20 (19.4%) had an underlying genetic syndromic, chromosomal, and/or other anomalies.[6] The investigators attributed the high rate of such anomalies to a high rate of consanguinity among the studied population.

  • In a 2013 retrospective study (2002-2010), Nigerian investigators at a tertiary teaching hospital found 460 of 7401 neonates had surgical conditions, of which 408 (88.7%) were congenital anomalies, including 101 (24.8%) neural tube defects.[7]

  • In another 2013 retrospective study (2003-2011), Turkish investigators found 100 of 8408 infants (1.2%) admitted to the NICU in a tertiary care hospital were diagnosed with neural tube defects; 74% of the mothers were graduates of primary school or illiterate, and none had used preconception folic acid.[8]

A worldwide decline in neural tube defect births has been recognized over the past 3 decades. For example, in the United States, New England has seen the incidence of spina bifida drop from 2.31 per 1000 births during the 1930s to 0.77 per 1000 births during the 1960s.

Reasons for the dramatic drop are not completely clear; however, certain factors probably play a part. The decline in neonates with neural tube defects paralleled the development of commonly used prenatal screening tests such as alpha-fetoprotein (AFP) and ultrasonography. Termination of pregnancy increased 50-fold in the British Isles after the introduction of prenatal screening. Termination of pregnancy probably accounted for a significant amount of the decline of neural tube defects in the United States. In Atlanta in the early 1990s, more than 30% of affected pregnancies were terminated based on prenatal test results. When epidemiologic analysis is complete. The use of periconception folate in the United States has reduced the incidence of neural tube defects since the late part of the 20th century.

In September of 1992, the US Public Health Service made the following strong recommendation: All women of childbearing age in the United States who are capable of becoming pregnant should consume 0.4 mg folic acid per day for the purpose of reducing the risk of having a pregnancy affected with spina bifida and other neural tube defects. Because the effects of high intakes are not well known, but include complicating the diagnosis of vitamin B-12 deficiency, care should be taken to keep total consumption less than 1 mg per day, except under the supervision of a physician.[9]

That statement and the abundance of scientific data available to the public have reinforced the observation that risk of delivering a child with a neural tube defect significantly decreases with the ingestion of periconception folate.[3, 4, 9]

The evidence of reduction in neural tube defects after folic acid fortification has continued to mount. In 1998, folic acid fortification in specific foods such as cereal became mandatory in Canada, a country in which the prevalence of neural tube defects was higher in the eastern provinces compared with the western provinces. In 2007, scientists in Canada published a population-based study in the New England Journal of Medicine, in which they analyzed the effect of this fortification.[10] The observed reduction in incidence rates of neural tube defects due to food fortification with folate included a 53% decrease of spina bifida cases, a 38% reduction in anencephaly cases, and a 31% reduction in encephalocele cases.[10, 11]

Incidence of neural tube defects such as anencephalus and spina bifida seems to be higher in people of Celtic descent, such as the Welsh, Irish, and Scottish. Their prevalence rate is significantly higher than the incidence rate seen in persons of Anglo-Saxon or Norman origin. In the United States, the highest rates of neural tube defects are found in Boston in people of Irish descent. In contradistinction, Africans, blacks, and Asians seem to have very low incidence of neural tube defects. Recurrence risk of giving birth to a second child with a neural tube defect varies with incidence. Investigators found the risk of having an additional affected birth after an anencephalic or spina bifida birth to be approximately 10.4% in Belfast but only about 4.12% in London. The risk in the United States is 1-3%.

The sex difference seems to be consistent in most studies. About 55-70% of neural tube defects occur in females. This female predominance is seen in both still and live births.[10]



The human embryo passes through 23 stages of development after conception, each occupying approximately 2-3 days. Two different processes form the central nervous system (CNS). The first is primary neurulation, which refers to the formation of the neural structures into a tube, thereby forming the brain and spinal cord. Secondary neurulation refers to the formation of the lower spinal cord, which gives rise to the lumbar and sacral elements. The neural plate is formed at stage 8 (days 17-19), the neural fold occurs at stage 9 (days 19-21), and the fusion of the neural folds occurs at stage 10 (days 22-23). Any disruption during stages 8-10 (ie, when the neural plate begins its first fold and fuses to form the neural tube) can cause craniorachischisis, the most severe form of neural tube defect (NTD).

Stage 11 (days 23-26) is when the closure of the rostral neuropore occurs. Failure at this point results in anencephaly, shown below.

Autopsy specimen on a child with anencephaly. This Autopsy specimen on a child with anencephaly. This is one of the most common CNS malformations in the West. The neonate, like almost all with such a severe forms of neural tube defects, did not survive more than a few hours or days. This malformation represents a failure of the anterior neuropore to close. This photograph also reveals an absence of the calvaria and posterior bone elements of the cervical canal, as well as the deficiency in the prosencephalon. Photo courtesy of Professor Ron Lemire.
Ventral view of a child with anencephaly that, lik Ventral view of a child with anencephaly that, like the previous picture, shows the loss of cranium and enclosed nervous tissue. In addition to the primary defect in development, a secondary destruction of nervous tissue occurs. Direct exposure to the caustic amniotic fluid causes progressive destruction of the remaining neural structures and secondary proliferation of a thin covering of vascular and glial tissue. Photo courtesy of Professor Ron Lemire.

Myelomeningocele is a result of disruption of stage 12 (days 26-30), closure of the caudal neuropore. Beyond day 26, a disruption is unlikely to be able to cause an NTD such as myelomeningocele, shown below.[12]

Neonate with a lumbar myelomeningocele with an L5 Neonate with a lumbar myelomeningocele with an L5 neurologic level. Note the diaphanous sac filled with cerebrospinal fluid and containing fragile vessels in its membrane. Also, note the neural placode plastered to the dorsal surface of the sac. This patient underwent closure of his back and an untethering of his neural placode. The neural placode was circumnavigated and placed in the neural canal. A dural sleeve was fashioned in such a way to reconstruct the neural tube geometry.

Studies on mice embryos have provided some unifying theories for explaining the associated anomalies seen with neural tube defects. Associated defects include hydrocephalus and hindbrain malformations such as Chiari II malformation. In 1992, McLone and Naidich proposed a unifying theory of neural tube defects that explains both the hindbrain anomalies and the spinal cord anomalies.[13] According to these investigators, the initial event is a failure of the neural folds to close completely, leaving a dorsal defect or myeloschisis. This permits the cerebral spinal fluid (CSF) to leak from the ventricles through the central canal into the amniotic fluid and causes collapse of the primitive ventricular system.

Failure of the primitive ventricular system to increase in size and volume leads to both downward and upward herniation of the small cerebellum. In addition, the posterior fossa does not develop to its full size, and the neuroblasts do not migrate outward at a normal rate from the ventricles into the cortex. Therefore, the panoply of defects occurs from an initial inciting event.

The precise genes (overexpressed or underexpressed) involved in this event have not been identified. The sonic hedgehog (Shh) gene has been identified in defects that cause hydrocephalus secondary to holoprosencephaly. This gene is believed to induce growth of the neural plate and helps close the neural tube by exerting a strong influence on the ventral and medial structure of the prosencephalon. The precise relationship of the Shh gene with neural tube defects is yet to be defined. Many mutant and gene-targeted mouse models can develop cranial and spinal neural tube defects. Some studies appear to indicate that a single molecular signaling cascade, called the planar polarity pathway, is the cause of the neural tube defect in the mutant murine model. Below is a table with the suspected embryologic event and result.

Table 1. Human CNS Malformations (Open Table in a new window)

Days of Gestation


Resultant Malformation


Formation of 3 germ layer and neural plate

Death or unclear effect


Formation of neural plate and groove form

Anterior midline defects


Appearance of optic vessels

Hydrocephalus (18-60 d)


Close anterior neuropore



Close posterior neuropore

Cranium bifidum, spina bifida cystica, spina bifida occulta


Vascular circulation

Microcephaly (30-130 d), migration anomalies


Splitting of prosencephalon to make paired telencephalon



Formation of corpus callosum

Agenesis of the corpus callosum



Over the last century, teratogens implicated in the etiology of neural tube defects (NTDs) in experimental animals and in humans include potato blight, hyperthermia, low economic status, antihistamine and sulfonamide use, nutritional deficiencies, vitamin deficiencies, and anticonvulsant use. Of all the suspected teratogens, carbamazepine, valproic acid, and folate deficiency have been most strongly tied to the development of neural tube defects. In humans, carbamazepine and valproic acid have been definitively identified as teratogens. Valproic acid is a known folate antagonist and its association with neural tube defects may be through that action. A woman taking valproic acid during pregnancy has an estimated risk of 1-2% of having a child with a neural tube defect. Therefore, women taking antiepileptic drugs during pregnancy are advised to undergo routine prenatal screening with AFP.

In the 1970s, Smithells first advanced the concept that nutrition may be related to the development of neural tube defects.[14, 15, 16] He noted that women with low erythrocyte folate and leukocyte ascorbic acid levels during the first trimester of pregnancy carried fetuses more commonly affected by neural tube defects than in controls. His early work led to two important randomized controlled studies on the use of periconception folate by British and Hungarian research groups.

The Medical Research Council in Britain performed a prospective, randomized, double-blind, multicenter trial to determine if women who previously delivered children with neural tube defects could lower the recurrence rate with multivitamins or folate (4 mg/d).[17] Thus, 1817 women who had a previous child with an neural tube defects were compared with 1195 women who had children without neural tube defects were randomized into four groups. One group received multivitamins, one group received folate, the third group received both, and the fourth group received neither. The study was terminated early when a significant protective effect was observed in the groups that received folic acid compared with the groups that did not. Multivitamins alone had no significant protective effect. Folic acid ingestion in the preconception period prevented an estimated 72% of predicted recurrent neural tube defects. The article with this conclusion was published in Lancet in 1991.

Hungarian investigators performed a randomized, double-blind, multicenter trial of folic acid to determine if it exerted a protective effect for a first occurrence of neural tube defects. One group of 2104 women received 0.8 mg of folic acid with their multivitamins, whereas the second group of 2052 women received no folic acid with their multivitamins. The folic acid group had no cases of NTD, while the non–folic acid group had 6 cases. This finding, published in the New England Journal of Medicine in 1992, indicated that ingestion of preconception folic acid significantly decreased the first occurrence of neural tube defects.[18] For this reason, the US Public Health Service issued their strongly worded recommendation to women of childbearing age to take folic acid supplements.

The precise mechanism by which folic acid is protective is unclear. Bjorkland hypothesized that folic acid provides the methyl group used for posttranslational methylation of arginine and histidine in the regulatory domains of the cytoskeleton, which is required for neural tissue differentiation.[19]

Despite compelling experimental evidence, as well as clear public health recommendations, Botto et al reported that, by 2005, the effectiveness of the educational campaign promoting the use of periconceptual folate had less than desired results.[20] New cases of neural tube defects, potentially preventable by ingestion of folate, continue to surface in 13 birth registries in Europe. He suggested the integration or fortification of folate into food could help prevent some of these cases. However, food fortification is neither the only, nor the simplest answer. The results of folic acid food fortification, reported by Canfield et al in 2005, reveal a modest but not overwhelming benefit in reducing the incidence of neural tube birth defects.[21]

Thus, several important issues have been raised. Because only 50% or fewer of the pregnancies in the United States are planned, compliance with the request to ingest preconception folic acid is not always easy to achieve. The neural tube defects occurs before day 26 postfertilization, often before many women have discovered their pregnancies. Thus, folic acid is not protective unless ingested in the periconception period. Furthermore, folic acid supplementation can mask a vitamin B-12 deficiency that can cause neurologic damage in the deficient individual. For these reasons, ingesting daily folic acid as a component of a multivitamin tablet has become the preferred recommendation for women who are of reproductive age.[9]

The reported effects of maternal periconceptional smoking and alcohol consumption on the risk of neural tube defects is of interest. In 2008, results of a population-based, case-control study in California conducted from 1998-2003 were published.[22] Maternal alcohol use increased the risk of neural tube defects, whereas smoking was associated with a lower risk of neural tube defects. The proposed mechanism of these observations is elusive.


Spina bifida cystica

The two major types of defects seen with spina bifida cystica are myelomeningoceles and meningoceles. Cervical and thoracic regions are the least common sites, and lumbar and lumbosacral regions are the most common sites for these lesions.

Myelomeningocele is a condition in which the spinal cord and nerve roots herniate into a sac comprising the meninges. This sac protrudes through the bone and musculocutaneous defect. The spinal cord often ends in this sac, in which it is splayed open, exposing the central canal. The splayed-open neural structure is called the neural placode. This type of neural tube defect is the subject of most of this article and is shown below.

Neonate with a lumbar myelomeningocele with an L5 Neonate with a lumbar myelomeningocele with an L5 neurologic level. Note the diaphanous sac filled with cerebrospinal fluid and containing fragile vessels in its membrane. Also, note the neural placode plastered to the dorsal surface of the sac. This patient underwent closure of his back and an untethering of his neural placode. The neural placode was circumnavigated and placed in the neural canal. A dural sleeve was fashioned in such a way to reconstruct the neural tube geometry.

Certain neurologic anomalies, such as hydrocephalus and Chiari II malformation (discussed below), accompany myelomeningocele. In addition, myelomeningoceles have a higher incidence of associated intestinal, cardiac, and esophageal malformations, as well as renal and urogenital anomalies. Most neonates with myelomeningocele have orthopedic anomalies of their lower extremities and urogenital anomalies due to involvement of the sacral nerve roots.

A meningocele is simply herniation of the meninges through the bony defect (spina bifida). The spinal cord and nerve roots do not herniate into this dorsal dural sac. These lesions are important to differentiate from myelomeningocele because their treatment and prognosis are so different from myelomeningocele. Neonates with a meningocele usually have normal findings upon physical examination and a covered (closed) dural sac. Neonates with meningocele do not have associated neurologic malformations such as hydrocephalus or Chiari II.

A subtype of spina bifida is called lipomeningocele, or lipomyelomeningocele, which is a common form of neural tube defect treated by pediatric neurosurgeons. These lesions have a lipomatous mass that herniates through the bony defect and attaches to the spinal cord, tethering the cord and often the associated nerve roots. The lipomyelomeningocele can envelop both dorsal and ventral nerve roots, only the dorsal nerve roots, or simply the filum terminale and conus medullaris. These lesions do not have associated hydrocephalus but have a more guarded prognosis than simple meningoceles. The surgical correction of these lesions is more complex, and the retethering rate, in which an additional surgery is required, is as high as 20% in some series.

In a third, rare type of spina bifida cystica called myelocystocele, the spinal cord has a large terminal cystic dilatation resulting from hydromyelia. The posterior wall of the spinal cord is often attached to the skin (ectoderm) and is undifferentiated, thus giving rise to a large terminal skin-covered sac. The vast majority of the lesions are dorsal, although a small minority (approximately 0.5%) are ventral in location. The most common ventral variant is an anterior sacral meningocele, which is most often discovered in females as a pelvic mass.

Spina bifida occulta

In this group of neural tube defects, the meninges do not herniate through the bony defect. This lesion is covered by skin (ie, closed), therefore rendering the underlying neurologic involvement occult or hidden. These patients do not have associated hydrocephalus or Chiari II malformations. Often, a skin lesion such as a hairy patch, dermal sinus tract, dimple, hemangioma, or lipoma points to the underlying spina bifida and neurologic abnormality present in the thoracic, lumbar, or sacral region. Presence of these cutaneous stigmata above the gluteal fold signifies the presence of an occult spinal lesion. Dimples below the gluteal fold signify a benign, nonneurologic finding such as a pilonidal sinus. This is an important point for differentiating the lesions that have neurologic involvement from those that do not.

An experienced pediatrician or surgeon should examine any neonate with cutaneous stigmata on the back around the gluteus. A good rule of thumb is that a lesion (eg, pit, tract) below the gluteal crease is often a pilonidal sinus and needs no further evaluation. Those tracts, pits, or lesions above the gluteal fold should be evaluated further.

Lesions that are questionable can be scanned with ultrasonography in a neonate or with MRI in an older child. Ultrasonography or MRI delineates the presence or absence of a tethered cord or other spinal anomaly. Plain radiology can reveal a panoply of anomalies, such as fused vertebrae, midline defects, bony spurs, or abnormal laminae. An MRI is often useful in evaluating for a split cord malformation (ie, diastematomyelia), in which a bony spur splits the spinal cord, or a duplication of the spinal cord and nerve roots (diplomyelia). More commonly, the neurosurgeon is searching for tethering of the spinal cord by a sinus tract or thickened filum that can cause traction on the spinal cord with subsequent neurologic deficits as the child grows.

A growing body of evidence indicates that the surgical repair of these lesions is more effective when performed prophylactically. Once the patient experiences a significant neurologic deficit, such as a neurogenic bladder or leg weakness, from these occult spinal lesions, the surgical remedy may not return the patient to the baseline neurologic status.

Signs and symptoms of occult spinal disorders in children include the following:

  • Radiologic signs: lamina defects, hemivertebrae, scoliosis, widening of interpedicular distance, butterfly vertebrae

  • Cutaneous stigmata: capillary hemangioma, caudal appendage, dermal sinus, hypertrichosis, orthopedic findings, extremity asymmetry, foot deformities

  • Neurological problems: weakness of leg or legs; leg atrophy or asymmetry; loss of sensation, painless sores; hyperreflexia; unusual back pain; abnormal gait; radiculopathy

  • Urologic problems: neurogenic bladder; incontinence

Cranium bifida

Several types of midline skull defects are classified under this term, ranging from simple (with minimal clinical significance) to serious life-threatening conditions. The most benign type of cranium bifidum occultum is the persistent parietal foramina or persistent wide fontanelle. The parietal foramina can be transmitted as an autosomal dominant trait via a gene located on the short arm of chromosome 11. The condition is sometimes called "Caitlin marks," after the family for which it was described. Both parietal foramina and a persistent anterior fontanelle are generally asymptomatic and a pediatric neurosurgeon may be asked to evaluate the child for skull fracture, craniosynostosis, or some other reason related to these findings. The best management is longitudinal observation, as these skull defects often close over time.

Cranium bifidum, such as an encephalocele, is much more serious. Encephaloceles are theorized to occur when the anterior neuropore fails to close during days 26-28 of gestation. Incidence of this anomaly is 10% of the incidence of spina bifida cystica. In the United States, approximately 80% of lesions are found on the dorsal surface of the skull, as shown below, with most near the occipital bone.

Neonate with a large occipital encephalocele lying Neonate with a large occipital encephalocele lying in the prone position prior to surgical intervention. Note the large skin-covered sac that represents a closed neural tube defect. Often called cranium bifidum, it is a more serious condition that represents a failure of the anterior neuropore to close. In this patient, a defect in the skull base (basicranium) was associated with this large sac filled with cerebrospinal fluid and a small, disorganized remnant of brain. The patient fared satisfactorily after the surgery in which the encephalocele was excised. However, the patient needed placement of a ventricular-peritoneal shunt to treat the resultant hydrocephalus, which is not uncommon. At age 5 years, the child was doing well and had only moderate developmental delay.

In contradistinction, most encephaloceles in Asia are ventral and involve the frontal bone. In the Philippines and other Pacific Rim countries, incidence of anterior encephaloceles that present as hypertelorism, obstructed nares, anterior skull masses, and cleft palate, among other presentations, is high. In most lesions, the sac that has herniated through a midline skull defect is covered with epithelium.

A small number of encephaloceles are associated with syndromes such as Meckel-Gruber syndrome. This syndrome is characterized by an occipital encephalocele that is associated with holoprosencephaly, orofacial clefts, microphthalmia, polycystic kidneys, and cardiac anomalies. This condition is autosomal recessive and has been mapped to chromosome bands 17q21-q24. In the United States, only about 30% of occipital encephaloceles contain cerebral cortex. The rest contain cerebellar tissue, dysplastic tissue with little normal function, glial tissue, or are simple meningeal sacs filled with CSF (as in cranial meningocele).

An MRI is invaluable in planning a surgical approach. The surgeon needs to know the contents of the sac, which can be quite large. In addition, the surgeon needs to know the relationship of the major cerebral venous sinuses to the sac in order to plan a safe operative approach. Finally, the surgeon needs to know if the patient has hydrocephalus. Approximately 60% of these patients require placement of a ventricular peritoneal (VP) shunt after the removal of their encephaloceles. Children whose encephaloceles contain large quantities of cerebral cortex often become microcephalic and display significant subsequent developmental and learning disabilities.


Anencephaly is the most severe form of neural tube defect. Rachischisis and craniorachischisis, often used as synonyms, refer to a severe deformity in which an extensive defect in the craniovertebral bone causes the brain to be exposed to amniotic fluid. Neonates with anencephaly rarely survive more than a few hours or days. Historically, these children have been the subject of myths, folklore, and superstitions, and have been referred to as monsters based on their unusual and frightening appearance. See the images below. Scientists have studied this malformation because it serves as a paradigm of the other dysraphic states.

Autopsy specimen on a child with anencephaly. This Autopsy specimen on a child with anencephaly. This is one of the most common CNS malformations in the West. The neonate, like almost all with such a severe forms of neural tube defects, did not survive more than a few hours or days. This malformation represents a failure of the anterior neuropore to close. This photograph also reveals an absence of the calvaria and posterior bone elements of the cervical canal, as well as the deficiency in the prosencephalon. Photo courtesy of Professor Ron Lemire.
Ventral view of a child with anencephaly that, lik Ventral view of a child with anencephaly that, like the previous picture, shows the loss of cranium and enclosed nervous tissue. In addition to the primary defect in development, a secondary destruction of nervous tissue occurs. Direct exposure to the caustic amniotic fluid causes progressive destruction of the remaining neural structures and secondary proliferation of a thin covering of vascular and glial tissue. Photo courtesy of Professor Ron Lemire.

The fetus has a partially destroyed brain, deformed forehead, and large ears and eyes with often relatively normal lower facial structures. Both genetic and environmental insults appear to be responsible for this outcome. The defect normally occurs after neural fold development at day 16 of gestation but before closure of the anterior neuropore at 24-26 days' gestation.

A variety of teratogens have been implicated, including radiation, folic acid deficiency, drugs, and infections. Regardless, three basic defects occur in the developing fetus. The first is the defect in notochord development, which results in failure of the cephalic folds to fuse in the midline and make a normal neural tube. The next defect is failure of the mesoderm to develop; mutual induction of all three germ layers in a temporally related sequence fails to occur. Therefore, the calvaria and vertebrae (mesoderm) fail to form correctly, exposing the brain to further insult. Finally, this skull and dural defect permits the brain to be exposed to amniotic fluid, thus destroying the developing forebrain neural cells.

Anencephaly is the most common major CNS malformation in the Western world, and no neonates survive. It is seen 37 times more frequently in females than in males. The recurrence rate in families can be as high as 35%. The incidence is highest in Ireland, Scotland, Wales, Egypt, and New Zealand and lowest in Japan.


If the mother decides not to terminate a pregnancy in which the fetus is affected with a neural tube defect, extensive counseling should ensue.[3] Education is provided on optimal prenatal care and expectations once a child is born. If diagnosed early enough, a discussion of fetal surgery is warranted. Currently, this option is available at only a few major centers, including Vanderbilt Medical Center, University of Pennsylvania, and Stanford Medicine; however, the number is growing. Specialists at the University of Pittsburgh Medical Center performed their first in-utero surgery to close an open neural tube defect in January 2019.[23]  Preliminary evidence suggests that this experimental approach has promise in decreasing resultant neurologic problems in the neonate. Long-term outcome data are currently lacking.

If conventional delivery is chosen, the study by Shurtleff and his colleagues is important to note.[24] Infants with neural tube defect who were exposed to labor and vaginal delivery were more than twice as likely to have severe paralysis or motor deterioration than those who undergo Cesarean delivery without labor. Although this remains a controversial point, most centers, such as that of the author, recommend a Cesarean delivery prior to labor in mothers carrying a fetus with a myelomeningocele.



Laboratory Studies

The presence of open neural tube defects (NTDs) can be detected with the measurement of alpha-fetoprotein (AFP) in the amniotic fluid or maternal bloodstream. AFP is the major serum protein in early embryonic life and is 90% of the total serum globulin in a fetus. It is believed to be involved in preventing fetal immune rejection and is first made in the yolk sac and then later in the GI system and liver of the fetus. It goes from the fetal blood stream to the fetal urinary tract, where it is excreted into the maternal amniotic fluid. The AFP can also leak into the amniotic fluid from open neural tube defects such as anencephaly and myelomeningocele, in which the fetal blood stream is in direct contact with the amniotic fluid.

The first step in prenatal screening is measuring the maternal serum AFP at 15-20 weeks' gestation. A patient-specific risk is then calculated based on gestational age and AFP level. For example, at 20 weeks' gestation, a maternal serum AFP concentration higher than 1,000 ng/mL would be indicative of an open neural tube defect. Normal AFP concentration in the maternal serum is usually lower than 500 ng/mL.

Determining precise gestational age is essential because fetal AFP levels are age specific and can peak in a normal fetus at 12-15 weeks' gestation. The measurement of maternal serum AFP levels is more than 75% accurate in detecting an open neural tube defect at more than 15 weeks' gestation. In patients in whom a question persists, amniotic AFP can be obtained. It is a significantly more accurate test, especially at 15-20 weeks' gestation, and detects approximately 98% of all open neural tube defects, although this method is not the preferred screening test. Amniotic fluid acetylcholinesterase levels add an increased degree of resolution.

A partial list of the fetal anomalies that are associated with elevated AFP levels is as follows:

  • Anencephaly

  • Spina bifida cystica

  • Encephalocele (leaking)

  • Conjoined twins

  • Omphalocele

  • Turner syndrome

  • Gastroschisis

  • Exstrophy of the cloaca

  • Oligohydramnios

  • Sacrococcygeal teratoma

  • Polycystic kidneys

  • Fetal death

  • Urinary tract obstruction

Imaging Studies

Detection of a neural tube defect with fetal ultrasonography in the hands of a skilled ultrasonographer is usually 98% specific. False-positive findings can result from multiple pregnancies or inaccurate fetal dating. However, closed neural tube defects can sometimes remain undetected, especially in cases of skin-covered lipomyelomeningoceles and meningoceles, in which the AFP levels may also be normal. These closed neural tube defects comprise about 10% or more of total neural tube defects discovered. A skilled ultrasonographer can detect these lesions with almost 95% sensitivity.



Medical Therapy

Neurologic lesions

The myelomeningocele is a saccular protrusion containing a neural placode bathed in cerebral spinal fluid (CSF), as shown below.

Neonate with a lumbar myelomeningocele with an L5 Neonate with a lumbar myelomeningocele with an L5 neurologic level. Note the diaphanous sac filled with cerebrospinal fluid and containing fragile vessels in its membrane. Also, note the neural placode plastered to the dorsal surface of the sac. This patient underwent closure of his back and an untethering of his neural placode. The neural placode was circumnavigated and placed in the neural canal. A dural sleeve was fashioned in such a way to reconstruct the neural tube geometry.

The surface of the sac is covered by arachnoid but no dura or skin. The sac appears velvety red or yellow with thin fragile vessels embedded in the arachnoid. The nerve roots pass forward into the sac and the spinal cord remains tethered to the bony defect in the spine. In many cases, the spinal cord is attached to the superior aspect of the sac. The myelomeningocele has many other associated CNS anomalies that require attention.

Table 2. Anomalies of the CNS Associated with Myelomeningocele (Open Table in a new window)

Anomalies Associated with Myelomeningocele

Approximate Percent of Patients

Chiari II malformation






Brainstem malformations (cranial nerve)


Cerebral ventricle abnormalities


Cerebellar heterotopias


Cerebral heterotopias


Agenesis of the corpus callosum





Chiari II malformation

Symptoms of a Chiari II malformation can occur any time after birth and very few patients require decompression after their first year of life for a symptomatic Chiari II malformation. The symptomatic Chiari II presentation can be as subtle as new hoarseness and pneumonia or as obvious as a progressive quadriparesis. A brain and cervical cord MRI in patients with myelomeningocele invariably demonstrates a Chiari II malformation with a herniated vermis and syringomyelia. The surgeon must first and foremost check to see if the ventricular peritoneal (VP) shunt apparatus is functioning. Most of the time, a partial or complete obstruction of a VP shunt (based on a shunt tap or surgical exploration) is the etiology of the new brainstem findings. A shunt malfunction causes the hindbrain to herniate and compress the cord, thus causing many of the presenting symptoms. Timely repair of the shunt leads to a good outcome with reversal of most deficits.

Hindbrain anomalies

Pathophysiology of Chiari malformations has fascinated neurosurgeons and provided a constant stream of literature for the past century on the presentation and presumed etiology. Although originally thought to be a rare neuroembryological disorder associated with neural tube defects, Chiari malformations have been recognized with increased frequency over the past 5 decades, temporally associated with the widespread application of MRI. Another increase in patient referrals has occurred relatively recently with improved understanding of the rather wide spectrum of clinical presentation.

In 1883, John Cleland published "Contribution to the study of spina bifida, encephalocele and anencephalus" in the Journal of Anatomy and Physiology. Cleland made several novel observations regarding hindbrain malformations on infant autopsy specimens. He described an elongated brainstem and cerebellar vermis, which protruded into the cervical canal in a full-term infant with spinal bifida and craniolacunae. Eight years later, Hans Chiari, professor of morbid anatomy at Charles University in Prague, published similar observations on congenital anomalies in the cerebellum and brain stem and commented on the a priori contributions of Cleland. Chiari further separated his patients into three different classifications of hindbrain abnormality; to ensure no confusion, the descriptions were accompanied by beautiful and detailed illustrations first in 1891, and then later in 1896.

Many textbooks and papers still refer to these hindbrain malformations as Arnold-Chiari malformations. However, the name Arnold-Chiari malformation is not historically accurate. The relatively minor contribution of Arnold to the understanding of this malformation was a report in 1894, which consisted of a description of one infant with a teratoma and cerebellar herniation. In 1907, students of Arnold, namely Schwalbe and Gredieg, erroneously suggested the term Arnold-Chiari Malformation. Unfortunately, this 1907 article failed to correctly attribute the rather significant contributions of Cleland. The subsequent 100 years have not corrected this misnomer. Attempts to name this malformation, Cleland-Arnold-Chiari or Cleland-Chiari malformation have not succeeded. Therefore, for the remainder of this article, the author adheres to a more historically accurate term and refers to these hindbrain anomalies simply as Chiari malformations.

The different Chiari malformations of the hindbrain were later classified as Chiari types I-III, terms that have been employed in a relatively consistent manner over the last century. These lesions are at the extreme ends of the spectrum, and patients with these anomalies are difficult to treat from a surgical perspective.

Type I is described as downward herniation of the cerebellar tonsils through the foramen magnum. Type II malformation is herniation of the cerebellar vermis and brainstem below the foramen magnum. Type II malformation also has kinking of the cervicomedullary junction, an upward trajectory of the cervical nerve roots, and associated syringomyelia. The medulla often protrudes below the foramen magnum and into the spinal canal, compressing the cervical cord. The medulla then buckles dorsally and forms a "medullary kink." Also, the fourth ventricle often is below the foramen magnum, and the midbrain tectum forms a sharp corner on midsagittal MRI and looks like a beak. Type II malformations are the subject of this section. Type III malformation is essentially a posterior fossa encephalocele or a cranium bifidum with herniation of the cerebellum through the posterior fossa bone and is a more severe neural tube defect.

The only deviation from the consistent terminology described above is the eponym Chiari type IV malformation. The Chiari type IV malformation consists of cerebellar hypoplasia, not herniation, and is no longer considered a Chiari malformation.

Description and diagnostic studies

A Chiari II malformation is downward displacement of the cerebellar vermis, fourth ventricle, and brainstem below the foramen magnum into the cervical canal, as shown below.

Sagittal T1 MRI image of a child with a myelomenin Sagittal T1 MRI image of a child with a myelomeningocele and associated Chiari II malformation. Note the cerebellar vermis and part of the brainstem has herniated below the foramen magnum and into the cervical canal (arrow). This patient had multiple brainstem symptoms and findings to include stridor and cranial nerve paresis (cranial nerves III, VI, IX, X) despite having a well-functioning ventricular-peritoneal shunt. He required a posterior fossa decompression of his hindbrain in order to relieve the symptoms of hindbrain herniation and brainstem compression. A minority of myelomeningocele patients require a Chiari II decompression. Those that do usually present in their first year of life with similar symptoms, stridor and cranial nerve paresis. A functioning shunt is imperative prior to exploring the posterior fossa in these children. Often times, especially in older children, a shunt revision may alleviate some of the symptoms of hindbrain compression.

The terms "hindbrain herniation, displacement, descent," and "ectopia" have been used synonymously in a wide range of posterior fossa conditions. From a historical point of view (prior to MRI), the diagnosis of Chiari II malformations was most often made using autopsy, air or contrast myelogram, or CT/myelography. Thus, the diagnosis was made infrequently, although all patients with myelomeningocele were thought to have a Chiari II malformation.

The radiological diagnosis is made using MRI. The crucial measurement in relation to descent of the hindbrain and vermis below the foramen magnum usually is assessed on sagittal section of MRI. The hindbrain or vermis displacement is measured from a straight line drawn between the basion to the opisthion of the foramen magnum. A perpendicular line dropped from the basion/opisthion line to the vermis tip is considered the extent of the herniated brain.

Syringomyelia is a cavitation of the spinal cord whose walls are composed of glial tissue, whereas hydromyelia is a cavitation or dilatation of the central canal lined by ependyma. The author uses the term syringomyelia in this article, instead of the more descriptive term syringohydromyelia, to avoid generating scientific and semantic confusion. The association of Chiari II malformation with syringomyelia varies from 80-90%, depending on the patient population studied.

Syringomyelia, the common finding associated with Chiari malformation, is derived from the Greek words, syrinx (meaning tube or pipe) and muelos (meaning marrow). Estienne, from France, first described the spinal cord cavitation called syringomyelia in human cadavers in 1546. In 1824, Charles Ollivier d'Angers provided the very descriptive name syringomyelia to the cylindrical dilatation of the spinal cord, which, in his illustrative case report, communicated with the fourth ventricle. In 1892, Abbe and Coley from New York performed a myelotomy to drain the syrinx cavity. This was the first recorded surgical procedure to treat syringomyelia.

Hindbrain malformations are the leading cause of syringomyelia. This cavitation of the spinal cord usually is gradually progressive and can cause neurologic deterioration over time. Note the following:

  • The fluid in the syrinx is identical to the CSF found elsewhere in the subarachnoid space; therefore, theories based on aberrant CSF physiology are invoked to explain the relationship of syringomyelia in patients with Chiari II malformation. Nevertheless, the pathophysiologic mechanisms that cause these two disorders are not well understood.

  • Many excellent theories have been suggested; however, none have been conclusively proven or universally accepted. Examination of the spinal cord in many neonates with myelomeningocele reveals atrophic or poorly developed anterior horn cells, incomplete posterior horns, and small nerve roots.

Initial examination

The initial neurologic examination of a neonate born with a neural tube defect should focus on the neurologic sequelae of the neural tube defect. Specifically, evaluate (1) site and level of the lesion, (2) motor and sensory level, (3) presence of associated hydrocephalus, (4) presence of associated symptomatic hindbrain herniation (eg, Chiari II malformation), and (5) presence of associated orthopedic deformity.

The lesion is first examined after the birth of a neonate. Myelomeningocele is a consequence of failed closure of the dorsal neural tube. Thus, the lesion appears as a red, raw neural plate structure devoid of dura and skin covering. The sac comprising arachnoid laced with thin, fragile vessels can be filled with CSF escaping from the central canal. A meningocele, in contradistinction, does not have neural tissue in the sac and usually has a nearly complete skin covering.

Open neural tube defects should be immediately covered with a saline-moistened sponge to avoid rupture of the sac and drying of the exposed neural placode. Avoid using wet gauze, as the fibers can stick to the exposed tissue. The neonate is maintained and examined in the prone or lateral recumbent position. An intravenous line is placed, and feedings are held until a full assessment can be completed. The neonate is treated with systemic antibiotics consisting of ampicillin at meningitic doses and gentamicin. Common neonatal organisms, such as group B streptococci, and nosocomial organisms must be prevented from entering the CSF, especially through a leaking myelomeningocele.

The neonatologist, pediatric geneticist, pediatric neurosurgeon, and pediatric orthopedist should immediately evaluate the child. Possible cardiac abnormalities are evaluated with ultrasonography. Initial ultrasonography of the head may also be performed to evaluate for hydrocephalus. Urologic examination using ultrasonography followed by a complete pediatric urologic evaluation may be performed initially or at a later date. Orthopedic evaluation is performed shortly before discharge because as many as 10% of neonates with a neural tube defect may have hip dislocations. A higher motor level lesion, such as L3-L4, can predispose some children to hip dislocations due to the unopposed hip flexors. In addition, presence of a varus or valgus extremity disorder is documented.

The pediatric neurosurgeon carefully evaluates the patient to assess the site and type of lesion, including assessment of lower extremity function. Evaluate the symmetry of the motor and sensory levels affected by the neural tube defect. Flaccid paralysis below the L4 level may reveal a strong psoas, but not hip adduction, knee hyperextension, or foot inversion deformities. Flaccid paralysis of the foot with a weak gastrocnemius-soleus complex may result in foot dorsiflexion deformities.

Attention to the anus helps to assess sacral nerve root function. Flaccid musculature in the S2-4 region often presents with a flat buttocks, absence of a well-developed gluteal cleft, and a patulous anus with no anal wink. The thoracic or lumbar region may have a large hump due to kyphosis or scoliosis of the spine; this can be so severe that it impedes the ability to place skin flaps over the neural tube defect and may compromise the infant's respiratory function.

Head ultrasonography can be performed during the neonatal period to evaluate the extent of ventricular enlargement. Initially, the ventricles may be normal or only slightly enlarged. However, after the neural tube defect is surgically closed, the ventricles often enlarge. Incidence of hydrocephalus associated with myelomeningocele ranges from 80-95%. In two studies performed in the 1980s and 1990s, approximately 85-90% of all patients with neural tube defect required a VP shunt for progressive hydrocephalus. The highest incidence in shunt dependence occurs in thoracic lesions; the lowest incidence occurs in sacral lesions. The risk of shunt revision in this population may be no different from that of other children with shunts. Approximately 40-50% of all children with neural tube defects require shunt revision in the first year and approximately 10% every year after that.

An MRI may reveal defects in cellular migration in the cerebral cortices. These include gray matter heterotopia, schizencephaly, gyral abnormalities, agenesis and thinning of the corpus callosum, abnormal thalami, and abnormal white matter findings.

Meaningful surgical treatment of myelomeningocele was not undertaken until the invention of the shunt valve by Holter in the 1950s. Prior to that, closure of a myelomeningocele was possible, but the ensuing uncontrolled hydrocephalus decreased the chance of survival. In the 1980s, the US Department of Health and Human Services issued the Baby Doe directive, stating that medical and surgical treatment could not be withheld simply because a neonate is handicapped. Although the directive was struck down, the decision to operate on neural tube defects in neonates was already an accepted practice in the United States. Furthermore, outcome studies by McClone,[13, 25, 26] Shurtleff,[27] and others presented a more positive outcome than had previously been thought for these children.

Timing of myelomeningocele repair

In the 1960s, the birth of a patient with myelomeningocele was a neurosurgical emergency, and immediate closure of the defect was required. Studies have subsequently shown that closure within 48 hours is both safe and effective. A study by Charney et al comparing delayed closure (3-7 days) to immediate closure (within 48 hours) showed little difference in survival, ventriculitis, or worsening paralysis.[28] The implications of this study were immense: Surgeons could plan a deliberate but thorough evaluation of a neonate with a neural tube defect. Parents would have time to ask questions and be acclimated to the intensive surgical therapy that was about to commence. In the author's Children's Hospital setting, a great deal of time is spent performing a detailed workup and counseling parents. Closure is performed on the next available elective operative time, usually within 72 hours after birth.

Operative approach

The American College of Obstetricians and Gynecologists (ACOG) recommends maternal-fetal surgery for myelomeningocele at centers that have the expertise with the surgical intervention and the multidisciplinary teams, services, and facilities to provide the required intensive care.[5]

Any major procedure on a neonate with myelomeningocele must be performed in such a fashion as to avoid hypovolemia, hypothermia, and airway compromise. Operative techniques vary by institution but, in general, the goal is similar: to circumnavigate the neural placode without injuring any of the neural elements. Once that is completed, the neural placode is placed into the spinal canal.

The next step entails the identification and dissection of the dura. The neural placode is covered by the dura by a watertight closure. If the dura is absent, as sometimes occurs, the muscle fascia is reflected off the muscle and used to create a watertight tube to enclose the neural placode. Skin closure is achieved by mobilizing the skin from the underlying paraspinal fascia in an avascular plane. The skin is then closed in layers, and an attempt is made to ensure little tension is placed on the wound. The skin may look somewhat pale immediately after closure, especially if the slightest bit of tension is present on the wound.

Care is taken to avoid necrosis or ischemia of the skin flap. The skin closure is protected with a sterile dressing.

Shunt placement during myelomeningocele closure

Approximately 20% of all patients with myelomeningoceles have significant hydrocephalus at birth; another 60-70% of patients develop it after the myelomeningocele is closed. In select patients, placement of a shunt during the same operation for closure of a myelomeningocele is entirely reasonable. At the author's institution, patients who manifest ventriculomegaly after birth undergo shunt placement after myelomeningocele closure but while under the same anesthetic. Contemporaneous shunt placement not only decreases future anesthetic risk, but also decreases the chance of CSF leaking through the myelomeningocele closure.

Treatment of Chiari II malformations

In Chiari II malformations, decompression of the posterior fossa and/or cervical cord, with its variable anatomy, is surgically challenging and requires an experienced surgeon. The torcular can come in low near the foramen magnum, the cerebellum is often adherent to the medulla, and many venous sinuses are present. Catastrophic blood loss is the major risk when a sinus is inadvertently opened. Prior to decompressing a Chiari II malformation, ensure the shunt is functioning. CT scan findings can be misleading because ventricles can remain small despite an obstruction in the shunt. Shunt tap or exploration is the most reliable test prior to embarking on a Chiari decompression.

The main signs and symptoms of a Chiari II malformation that requires decompression are those of brainstem compression. For example, neonates can have stridor, central apnea, dysphagia, quadriparesis, or failure to thrive. Patients may have subtle signs, such as worsening strabismus, nystagmus, myelopathy, or aspiration of unclear etiology. In the author's experience, symptomatic Chiari II malformation is the leading cause of death in patients with myelomeningocele. (Approximately 30% of children die that develop brainstem symptoms when younger than 5 years.) Symptomatic deterioration from a Chiari II malformation can constitute a neurosurgical emergency and, despite urgent decompression, children can die from hindbrain compression. Patients who fare the worst are those who have ventilatory difficulties shortly after birth. Autopsies on these clinically challenging patients often show brainstem anomalies, such as disorganized brainstem nuclei, as well as cortical and subcortical abnormalities.

Signs and symptoms of problematic Chiari II malformation in neonates include the following:

  • Stridor with vocal cord paralysis

  • Central apnea

  • Aspiration

  • Dysphagia

  • Hypotonia

  • Progressive brainstem function

  • Myelopathy

  • Hypotonia, quadriparesis

  • Nystagmus, strabismus, progressive

  • Swallowing difficulties, poor suck


Although this skin-covered neural tube defect is beyond the scope of this article, a few salient points should be included here. The neonate often presents with a skin-covered mass above the buttocks, as shown below.

These 2 photographs depict the lumbar regions on 2 These 2 photographs depict the lumbar regions on 2 different children with closed neural tube defects. Both children have lipomyelomeningocele. The child in the left has a dorsal lipoma that is pedunculated. The child on the right has a more common-appearing lipomatous mass that is heaped up beneath the skin. Both lipomas lead from the subcutaneous tissue, through the dura and into the intradural space, where they are attached to the spinal cord. Photos courtesy of Professor J.D. Loeser.

The natural history of these lesions consists of eventual neurologic deterioration. Appropriate prophylactic surgical treatment of these lesions can halt the progression of the neurologic deficits and improve neurologic function, and the risk of surgery in skilled hands is quite low.

The surgical goal in treating these lesions is to detach the lipoma of the buttocks from the lipoma that emerges through the dura, fascia, and bony defect. The technique requires the surgeon to identify normal anatomy and travel down to the location where the lipoma pierces the dura and enters the spinal cord. Often with use of microsurgical technique and/or a carbon dioxide laser, the lipoma is disconnected from the spinal cord, as shown in the image below.

Photograph of a child undergoing a neurosurgical p Photograph of a child undergoing a neurosurgical procedure in which the spinal cord is being detached (untethered) from the intradural and extradural lipomatous mass that fixes it to the subcutaneous tissue. The white arrow shows the laser char on the lipoma that has been shaved off the spinal cord and was connected to the extradural mass. The black arrow shows the extradural lipoma, which crept through the dura and attached to the spinal cord, thereby firmly fixing the spinal cord at too low and too dorsal a location in the sagittal plane.

All of the lipoma need not be removed. Take care to leave some lipoma on the cord in order to avoid injuring the underlying neural substrate. The filum terminale also is divided to further untether the cord. A patulous graft is then placed over the dural opening to establish a pool of CSF around the cord to help prevent retethering.

For patient education resources, see Brain & Nervous System Center as well as Spina Bifida.

Surgical Therapy

Over the past 2 decades, fetal surgery for neural tube defects (NTDs), specifically myelomeningocele, has been developed. Interest in this approach to the treatment of neural tube defects stems from a growing body of literature that supports the 2-hit hypothesis. Initially, most investigators believed that all the neurologic deficits seen in neural tube defects resulted from the neurulation defect that occurs during days 26-28 of gestation. However, some have suggested that, in addition to the neurulation embryologic defect, secondary damage occurs when exposed neural tissue is in contact with amniotic fluid. Thus, covering the neural placode with skin in utero could theoretically decrease the damage inflicted to the exposed neural structures by amniotic fluid. In addition, the loss of cerebral spinal fluid (CSF) through the central canal may be halted by in utero closure of the neural placode, thereby reversing some of the potentially devastating neurologic sequelae of neural tube defects.

The two neurologic sequelae of major concern are shunt-dependent hydrocephalus and hindbrain injury from progressive hindbrain herniation through the foramen magnum (Chiari II malformation). In 1999, Vanderbilt University researchers, led by pediatric neurosurgeon Noel Tulipan, MD, and obstetrician Joseph P. Bruner, MD, reported in JAMA their experience with in utero surgery for neural tube defects over the previous decade.[29] This was a single-institution nonrandomized, observational study conducted from 1990-1999. A cohort of 29 patients with isolated myelomeningocele underwent intrauterine repair of the neural tube defect between 24-30 weeks' gestation. These patients were compared to 23 lesion-matched controls who underwent postnatal surgery. The main outcome measure was requirement for placement of a ventriculoperitoneal shunt for the treatment of hydrocephalus.

Results of the study were promising. Patients with neural tube defects who underwent in utero surgery experienced a lower incidence of hydrocephalus than the control group (59% versus 91%). Also, a reduced incidence of hindbrain herniation was evident in the in utero group (38% versus 95%). One death occurred in the in utero group, as did an increased risk of oligohydramnios (48% versus 4%), and an earlier age of delivery by about 4 weeks.

The results encouraged a group of investigators from both Vanderbilt and Children's Hospital of Pennsylvania (CHOP) to propose that a few select centers investigate whether this approach can yield durable results. The CHOP group published their results in The Lancet in 1998.[30] Since that proposal, the National Institutes of Health (NIH) funded the Management of Myelomeningocele Study (MOMS trial) to study the efficacy of in utero surgery in this patient population. Three centers are conducting this research: CHOP/University of Pennsylvania; Vanderbilt; and University of California, San Francisco.

Investigators for the MOMS demonstrated the success of in utero surgical repair for open NTDs.[31] This prospective randomized controlled trial compared fetuses with prenatally diagnosed myelomeningocele treated via standard postnatal repair vs in utero. Outcomes demonstrated a significant reduction in hydrocephalus, and thus need for ventriculoperitoneal shunt, reversal of hindbrain herniation, and decreased incidence of Chiari malformation. There was also improvement in spinal-neurologic functional outcomes as motor skills were superior in the fetal surgery group, and twice as many children were ambulating independently at 2.5 years of age relative to the post-natal surgery group. However, maternal complications were also observed, such as pre-term birth, placental abruption, need for future caesarean delivery, among others within the surgical cohort. Overall the trial demonstrated more favorable outcomes from prenatal treatment beyond the maternal risks from surgery.[32, 31, 33, 34]

The MOMS 2 trial is a follow-up study to evaluate outcomes at ages 5 to 8 years. The study will examine whether prenatal repair of myelomeningocele affects behavior, cognitive and motor functioning, brain morphology and microstructure, and other aspects of the health of the child at school age. The study will analyze the need for shunts and assistive devices, developmental milestones, and bowel and bladder function in these children. Investigators will also evaluate the impact of prenatal surgery on the reproductive health of the mother and the overall well-being of the family.[35]

Outcome and Prognosis

Major issues in evaluating the outcome of children with myelomeningocele are hydrocephalus, intellect, ambulation, continence, orthopedic problems, and employment and independent living status.

Treatment of neural tube defects (NTDs) in neonates has evolved over the past half century. Historically, there was a period when neonates with neural tube defects were either left untreated or selectively treated. The natural history of neonates with neural tube defects left untreated is poor. Most died of meningitis, hydrocephalus, and sepsis. Laurence described a cohort of 290 children with spina bifida (mostly myelomeningoceles) left untreated in Wales during the 1950s and 1960s.[36] Only 11% of those children lived past the first decade of life. Lorber and Salfield reported their results with selected treatment of neonates with myelomeningocele.[37] More than 80% of the selected neonates lived, whereas 97% of the neonates denied treatment died in the first year of life. The tremendous ethical implications of selected neonatal treatment led to its abandonment.

In the United States during the 1960s, most children with myelomeningocele were treated, which resulted in a higher survival rate (>80% for the first decade) than that in Great Britain. Recognized causes of death include shunt malfunction, seizure, infection, and uncontrolled brainstem symptoms from Chiari II malformations and/or hydrocephalus. During the past 3 decades, aggressive treatment of neonates with myelomeningocele has been pursued in almost all pediatric centers in the United States.


Cognitive ability is, in part, influenced by hydrocephalus, CNS infections, and degree of impairment. In most series, 60-70% of the children with myelomeningocele had intelligence quotients (IQs) greater than 80; the others had IQs in the delayed or severely delayed range. In the McLone series, children who had CNS infections, such as ventriculitis, or shunt infections fared worse than those who did not.[26] Children with myelomeningocele without hydrocephalus had an average IQ of 102; those with hydrocephalus had an average IQ of 95. However, the average IQ dropped to 73 when a CNS infection complicated the picture. Children with moderate physical impairments, in most series, have a better intellectual outcome than those with significant sensory levels and paraplegia. The reasons most likely are multifactorial.


Only 10-15% of all children with myelomeningoceles are continent of urine. This issue often causes the children to be separated from their peers, which, in turn, leads to other neuropsychologic deficits. Despite the development of catheters and Crede manipulation (pushing on the pelvis over the bladder to engender urination), children with NTDs still experience a high rate of infection, vesicoureteral reflux, kidney failure, hydronephrosis, and obstruction. Clean intermittent catheterization (CIC) has led to a marked improvement of the lifestyles and lifespan of these children. CIC can make more than 75% of these children socially continent and significantly decreases the rate of urosepsis. As a result of CIC, urinary diversions are less commonly performed. Use of anticholinergic drugs combined with CIC has resulted in a better self-image and greater educational and vocational opportunities for children with neural tube defects.

Bowel continence is achieved with a combination of medication, diet control, manual disimpaction, and enemas. Most patients with neural tube defects can be continent of stool with these measures.


The ability to ambulate is influenced by the level of the neural lesion, hydrocephalus, pelvic anatomy, limb deformities, tethered cord, scoliosis, kyphosis, and syringomyelia; varying degrees of ambulation are noted. Strong hip flexors, adductors, and quadriceps are required to be ambulatory. Some children can ambulate in the community, some only in the home, others can only stand but not walk, and the rest are wheelchair bound. However, many children with neural tube defects, such as lumbar myelomeningocele, lose their ability to ambulate as they get older. In general, patients with sacral lesions can ambulate, those with thoracic lesions cannot.

Independent living, vocation, education

Steinbok noted that about 60% of children with neural tube defects attended normal classes, and 40% were in special classes or operated below their grade levels.[12, 38] Approximately 10-40% of children with myelomeningocele are probably employable at some level, depending on the individual's intellectual abilities, ambulation status, and environmental influences.

Latex allergies

Over the past 2 decades, allergy to latex has been recognized in an increasing number of children with myelomeningocele. As many as 50% of children with myelomeningocele may be latex sensitive. This appears to be a result of a massive immunoglobulin E (IgE) response to the antigen in latex that is derived from the Heva brasiliensis plant. Patients with myelomeningocele should be treated from birth with latex precautions. Surgeons and health care providers should work with latex-free gloves and plastics so that they can avoid latex-induced anaphylaxis, which can be life threatening. Medications such as corticosteroids, diphenhydramine, bronchodilators, and epinephrine should be available as a precaution during surgery on these children.

Late complications

Neurosurgeons need to be wary of later-life neurologic deterioration in children and adults. The most common deterioration occurs from a tethered spinal cord. A routine MRI reveals a spinal cord that ends in the lumbar or sacral regions in almost all patients with myelomeningocele, shown below.

Sagittal T1-weighted MRI image of a child after cl Sagittal T1-weighted MRI image of a child after closure of his myelomeningocele. Child is aged 7 years. Note the spinal cord ends in the sacral region far below the normal level of T12-L1. It is tethered at the point in which the neural placode was attached to the skin defect during gestation. The MRI showed dorsal tethering, and the child complained of back pain and had a new foot deformity on examination. By definition, all children with a myelomeningocele have a tethered cord on MRI, but only about 20% of children require an operation to untether the spinal cord during their first decade of life, during their rapid growth spurts. Thus, the MRI must be placed in context of a history and examination consistent with mechanical tethering and a resultant neurologic deterioration.

This can be normal in many patients without any new neurologic complaints. Despite careful surgical closure of the original neural placode, approximately 20% or more of all patients with myelomeningocele require an untethering of their spinal cords later in life. They may present with gait difficulty, back pain, leg weakness, sensory loss, a new foot deformity, or simply a change in their urodynamic data or urinary continence. These patients require surgical exploration to free the neural placode and nerve roots from the dorsal surface of their dura. Patients with tethered cords on MRI but no new complaints do not require reexploration.

Diastematomyelia can be diagnosed using MRI or CT/myelogram. An enlarging syringomyelia can be the result of a symptomatic Chiari II malformation or retethering of the spinal cord. Many functional deteriorations result from progressive orthopedic deformities such as scoliosis, pelvic obliquity, and limb deformities. An orthopedic surgeon well versed in the care of patients with neural tube defects is required to execute a reasonable plan to repair or stabilize treatable disorders.

In general, a multidisciplinary team consisting of neonatologist, pediatrician, pediatric neurosurgeon, pediatric urologist, pediatric orthopedic surgeon, physical therapist, nurse, nutritionist, psychologist, and teacher are required to direct the care of children with neural tube defects.